Inactivation of Cancer Mutations Utilizing CRISPR/Cas9.

ABSTRACT: Although whole-genome sequencing has uncovered a large number of mutations that drive tumorigenesis, functional ratification for most mutations remains sparse. Here, we present an approach to test functional relevance of tumor mutations employing CRISPR/Cas9. Combining comprehensive sgRNA design and an efficient reporter assay to nominate efficient and selective sgRNAs, we establish a pipeline to dissect roles of cancer mutations with potential applicability to personalized medicine and future therapeutic use.

SUBMITTER: Gebler C 

PROVIDER: S-EPMC6284257 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature